Mitchel Sayare
Chairman chez ALTIMMUNE, INC.
Fortune : 268 375 $ au 31/03/2024
Profil
Mitchel B.
Sayare is currently the Chairman at Altimmune, Inc. He is also a Director at the Biotechnology Innovation Organization, Isabella Products, Inc., and Advanced Aesthetic Technologies, Inc. Previously, he served as a Director at ImmuCell Corp., ImmunoGen, Inc., Theraclone Sciences, Inc., CymoGen Dx LLC, Boston IVF LLC, PharmAthene, Inc., Xenogen Corp., and Apoptosis Technology, Inc. He also worked as an Assistant Professor of Biophysics & Biochemistry at the University of Connecticut.
Dr. Sayare obtained his undergraduate degree from Ursinus College and his doctorate from Temple University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALTIMMUNE, INC.
0,05% | 28/09/2023 | 26 363 ( 0,05% ) | 268 375 $ | 31/03/2024 |
Postes actifs de Mitchel Sayare
| Sociétés | Poste | Début |
|---|---|---|
| ALTIMMUNE, INC. | Chairman | 01/01/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Isabella Products, Inc.
 Isabella Products, Inc. Specialty TelecommunicationsCommunications Isabella Products, Inc. develops wireless products. It offers Vizit, a two-way wireless digital photo frame, enables consumers to interact with billions of unshared images found within camera phones, computers, and the internet by combining touch screen display with wireless network capabilities, and Fable, a seven inch browser tablet built on an android operating system designed for children. The company was founded by Matthew I. Growney and is headquartered in Concord, MA. | Director/Board Member | 04/06/2010 |
Advanced Aesthetic Technologies, Inc.
 Advanced Aesthetic Technologies, Inc. BiotechnologyHealth Technology Advanced Aesthetic Technologies, Inc. engages in research and development of biotechnology in the aesthetic medical field. The company is headquartered in Brookline, MA. | Director/Board Member | - |
Anciens postes connus de Mitchel Sayare
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Chief Executive Officer | 31/12/2009 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Corporate Officer/Principal | 01/01/1985 |
| Apoptosis Technology, Inc. | President | - |
Boston IVF LLC
 Boston IVF LLC Medical/Nursing ServicesHealth Services Boston IVF, Inc. operates fertility clinics which offer reproductive technologies. The firm's services include IVF laboratory, consultations and evaluations, blood/ultrasound cycle monitoring, Semen analysis, IUI, hysterosalpingogram, Saline Infused Sonogram, patient education, Domar center for mind/body health and acupuncture. The company was founded by Merle Berger and Michael Alper in 1986 and is headquartered in Waltham, MA. | Director/Board Member | - |
CymoGen Dx LLC
 CymoGen Dx LLC Miscellaneous Commercial ServicesCommercial Services CymoGen Dx, LLC provided genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions. The company was headquartered in New Windsor, NY. | Director/Board Member | - |
Formation de Mitchel Sayare
| Ursinus College | Undergraduate Degree |
| Temple University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| IMMUCELL CORPORATION | Health Technology |
| IMMUNOGEN, INC. | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Isabella Products, Inc.
Isabella Products, Inc. Specialty TelecommunicationsCommunications Isabella Products, Inc. develops wireless products. It offers Vizit, a two-way wireless digital photo frame, enables consumers to interact with billions of unshared images found within camera phones, computers, and the internet by combining touch screen display with wireless network capabilities, and Fable, a seven inch browser tablet built on an android operating system designed for children. The company was founded by Matthew I. Growney and is headquartered in Concord, MA. | Communications |
CymoGen Dx LLC
CymoGen Dx LLC Miscellaneous Commercial ServicesCommercial Services CymoGen Dx, LLC provided genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions. The company was headquartered in New Windsor, NY. | Commercial Services |
Boston IVF LLC
Boston IVF LLC Medical/Nursing ServicesHealth Services Boston IVF, Inc. operates fertility clinics which offer reproductive technologies. The firm's services include IVF laboratory, consultations and evaluations, blood/ultrasound cycle monitoring, Semen analysis, IUI, hysterosalpingogram, Saline Infused Sonogram, patient education, Domar center for mind/body health and acupuncture. The company was founded by Merle Berger and Michael Alper in 1986 and is headquartered in Waltham, MA. | Health Services |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Advanced Aesthetic Technologies, Inc.
Advanced Aesthetic Technologies, Inc. BiotechnologyHealth Technology Advanced Aesthetic Technologies, Inc. engages in research and development of biotechnology in the aesthetic medical field. The company is headquartered in Brookline, MA. | Health Technology |
| Apoptosis Technology, Inc. |
